Archive for November 2023
Lexington biotech gets second FDA rejection this year
The U.S. Food and Drug Administration has rejected a drug made by a Lexington biotech just a few months after it rejected another drug by the same company. Read More
Read MoreArgenx drug meets surprise late-stage failure
A drug made by Dutch biotech argenx SE, which has U.S. offices in Cambridge, met a surprise failure in a late-stage study, sending share prices down on Tuesday morning. Read More
Read MoreTransgender woman sues employer, Harvard Pilgrim for discrimination
Lillian Bernier said her employer-sponsored health plan excluded coverage for gender-affirming care—and she’s arguing that exclusion violates state and federal discrimination laws. Read More
Read MoreUkrainian consumer software company opens Cambridge office
While the majority of MacPaw’s team is in Ukraine, this fall, the company embarked on a journey to expand globally. MacPaw has opened a new office in Cambridge and plans to grow its local team. Read More
Read MoreState Street Global Advisors taps new chief business officer for asset management
Boston-based State Street Global Advisors, the asset management business of State Street Corp., has tapped a longtime ETF industry leader as its new chief business officer. Read More
Read MoreMass General Brigham to build AI products with Australian health tech company
MGB and Annalise.ai plan to build AI radiology imaging tools, which can quickly scan X-rays and CT scans to alert clinicians to any health complications faster. Read More
Read MoreiRobot loses $200M in value after EU issues ‘preliminary view’ of Amazon deal
The European antitrust regulator released a statement on Monday saying that the acquisition of iRobot (Nasdaq: IRBT) "may restrict competition in the market for robot vacuum cleaners." Read More
Read MoreEarly-stage VC slump persists, but biotech is a bright spot
The biotech sector accounted for $580 million in investment across six deals last quarter, second only to AI and machine learning. Read More
Read MoreBraintree unveils MBTA zoning plan just weeks before deadline
The proposal includes rezoning three areas near Braintree’s Red Line T station as well as a fourth near the Weymouth border to allow for more multifamily housing. Read More
Read MoreCVS sues US gov’t over $400 million tax dispute
The Woonsocket-based pharmacy retail giant claims the federal government owes it a $400 million refund for a portion of its federal taxes paid between 2014 and 2017. Read More
Read More